{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:09:00Z","timestamp":1790759340792,"version":"4.1.0"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2020.00281","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T05:31:59Z","timestamp":1588224719000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Phosphorylation-Dependent Pin1 Isomerization of ATR: Its Role in Regulating ATR\u2019s Anti-apoptotic Function at Mitochondria, and the Implications in Cancer"],"prefix":"10.3389","volume":"8","author":[{"given":"Yetunde","family":"Makinwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip R.","family":"Musich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1523\/JNEUROSCI.3124-15.2016","article-title":"Pin1 modulates the synaptic content of NMDA receptors via prolyl-isomerization of PSD-95.","volume":"36","author":"Antonelli","year":"2016","journal-title":"J. Neurosci."},{"key":"B2","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1200\/JCO.2009.26.6452","article-title":"Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer.","volume":"28","author":"Arrieta","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B3","first-page":"6244","article-title":"The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.","volume":"63","author":"Ayala","year":"2003","journal-title":"Cancer Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1073\/pnas.042529199","article-title":"Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A.","volume":"99","author":"Brazin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1101\/gad.14.4.397","article-title":"ATR disruption leads to chromosomal fragmentation and early embryonic lethality.","volume":"14","author":"Brown","year":"2000","journal-title":"Genes Dev."},{"key":"B6","first-page":"635","article-title":"Phase I\/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.","volume":"4","author":"Budd","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1101\/gad.1685108","article-title":"How ATR turns on: TopBP1 goes on ATRIP with ATR.","volume":"22","author":"Burrows","year":"2008","journal-title":"Genes Dev."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15772","article-title":"A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action.","volume":"8","author":"Campaner","year":"2017","journal-title":"Nat. Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1158\/0008-5472.CAN-12-4360","article-title":"SENP1 deSUMOylates and regulates Pin1 protein activity and cellular function.","volume":"73","author":"Chen","year":"2013","journal-title":"Cancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2014.12.027","article-title":"Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer\u2019s disease.","volume":"76","author":"Chen","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0844-y","article-title":"Prolyl isomerase Pin1: a promoter of cancer and a target for therapy.","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","article-title":"The DNA damage response: making it safe to play with knives.","volume":"40","author":"Ciccia","year":"2010","journal-title":"Mol. Cell."},{"key":"B13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm2450","article-title":"ATR: an essential regulator of genome integrity.","volume":"9","author":"Cimprich","year":"2008","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1126\/science.1065521","article-title":"ATR and ATRIP: partners in checkpoint signaling.","volume":"294","author":"Cortez","year":"2001","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00726-013-1511-3","article-title":"Cis-trans isomerization of omega dihedrals in proteins.","volume":"45","author":"Craveur","year":"2013","journal-title":"Amino Acids"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1200\/JCO.2008.19.3797","article-title":"Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.","volume":"27","author":"Decensi","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nsmb1068","article-title":"A native to amyloidogenic transition regulated by a backbone trigger.","volume":"13","author":"Eakin","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"36575","DOI":"10.1074\/jbc.m504548200","article-title":"Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells.","volume":"280","author":"Eckerdt","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01477","article-title":"A guide to PIN1 function and mutations across cancers.","volume":"9","author":"El Boustani","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1200\/jco.1997.15.2.483","article-title":"Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.","volume":"15","author":"Estey","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2174\/156800908784293622","article-title":"Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer.","volume":"8","author":"Finn","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1021\/bi00461a001","article-title":"The mechanism of protein folding. Implications of in vitro refolding models for de novo protein folding and translocation in the cell.","volume":"29","author":"Fischer","year":"1990","journal-title":"Biochemistry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tibs.2010.09.005","article-title":"ATR: a master conductor of cellular responses to DNA replication stress.","volume":"36","author":"Flynn","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ctrv.2013.03.002","article-title":"Targeting ATR in DNA damage response and cancer therapeutics.","volume":"40","author":"Fokas","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.molcel.2015.06.029","article-title":"Pin1-induced proline isomerization in cytosolic p53 mediates BAX activation and apoptosis.","volume":"59","author":"Follis","year":"2015","journal-title":"Mol. Cell."},{"key":"B26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccr.2011.06.004","article-title":"A Pin1\/mutant p53 axis promotes aggressiveness in breast cancer.","volume":"20","author":"Girardini","year":"2011","journal-title":"Cancer Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s000180050299","article-title":"Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts.","volume":"55","author":"Gothel","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"17979","DOI":"10.1073\/pnas.1106198108","article-title":"Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin.","volume":"108","author":"Grison","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.2174\/1381612823666170703164711","article-title":"Dual roles of Pin1 in cancer development and progression.","volume":"23","author":"Han","year":"2017","journal-title":"Curr. Pharm Des."},{"key":"B30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.lungcan.2006.11.024","article-title":"Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases.","volume":"56","author":"He","year":"2007","journal-title":"Lung Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.1021\/bi973162p","article-title":"Selective inactivation of parvulin-like peptidyl-prolyl cis\/trans isomerases by juglone.","volume":"37","author":"Hennig","year":"1998","journal-title":"Biochemistry"},{"key":"B32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.molcel.2015.08.008","article-title":"ATR plays a direct antiapoptotic role at mitochondria, which is regulated by prolyl isomerase Pin1.","volume":"60","author":"Hilton","year":"2015","journal-title":"Mol. Cell."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1110\/ps.0241903","article-title":"An electronic effect on protein structure.","volume":"12","author":"Hinderaker","year":"2003","journal-title":"Protein Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/35078508","article-title":"Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis.","volume":"3","author":"Hsu","year":"2001","journal-title":"Nat. Cell. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1158\/0008-5472.CAN-13-0110","article-title":"ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status.","volume":"73","author":"Huntoon","year":"2013","journal-title":"Cancer Res."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175939","article-title":"Dynamic regulation of Pin1 expression and function during zebrafish development.","volume":"12","author":"Ibarra","year":"2017","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/j.clml.2013.08.004","article-title":"Single-agent liposomal all-trans-retinoic Acid as initial therapy for acute promyelocytic leukemia: 13-year follow-up data.","volume":"14","author":"Jain","year":"2014","journal-title":"Clin. Lymphoma Myeloma Leuk"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1158\/1078-0432.CCR-15-0479","article-title":"Molecular pathways: targeting ATR in cancer therapy.","volume":"21","author":"Karnitz","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1091\/mbc.e07-03-0237","article-title":"Inhibition of Pin1 reduces glutamate-induced perikaryal accumulation of phosphorylated neurofilament-H in neurons.","volume":"18","author":"Kesavapany","year":"2007","journal-title":"Mol. Biol. Cell."},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-019-02233-5","article-title":"Prognostic value of peptidyl-prolyl cis-trans isomerase 1 (PIN1) in human malignant tumors.","author":"Khoei","year":"2019","journal-title":"Clin. Transl. Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/ijc.30373","article-title":"Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells.","volume":"140","author":"Kim","year":"2017","journal-title":"Int. J. Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41568-018-0034-3","article-title":"Targeting ATR in cancer.","volume":"18","author":"Lecona","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"B43","first-page":"3909","article-title":"Ataxia-telangiectasia and RAD3-related and ataxia-telangiectasia-mutated proteins in epithelial ovarian carcinoma: their expression and clinical significance.","volume":"35","author":"Lee","year":"2015","journal-title":"Anticancer Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.molcel.2011.03.005","article-title":"Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function.","volume":"42","author":"Lee","year":"2011","journal-title":"Mol. Cell."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0611-7","article-title":"Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways.","volume":"11","author":"Lian","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/1535370215570829","article-title":"Landscape of Pin1 in the cell cycle.","volume":"240","author":"Lin","year":"2015","journal-title":"Exp. Biol. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.tibs.2011.07.001","article-title":"Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins.","volume":"36","author":"Liou","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.molcel.2011.06.019","article-title":"ATR autophosphorylation as a molecular switch for checkpoint activation.","volume":"43","author":"Liu","year":"2011","journal-title":"Mol. Cell."},{"key":"B49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-1-4615-4253-7_8","article-title":"Phosphorylation-dependent prolyl isomerization: a novel cell cycle regulatory mechanism.","volume":"4","author":"Lu","year":"2000","journal-title":"Prog. Cell. Cycle Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nchembio.2007.35","article-title":"Prolyl cis-trans isomerization as a molecular timer.","volume":"3","author":"Lu","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/380544a0","article-title":"A human peptidyl-prolyl isomerase essential for regulation of mitosis.","volume":"380","author":"Lu","year":"1996","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nrm2261","article-title":"The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease.","volume":"8","author":"Lu","year":"2007","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/cr.2014.109","article-title":"Prolyl isomerase Pin1 in cancer.","volume":"24","author":"Lu","year":"2014","journal-title":"Cell Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1158\/0008-5472.CAN-13-2785","article-title":"Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer.","volume":"74","author":"Luo","year":"2014","journal-title":"Cancer Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00294-019-01039-w","article-title":"Activation of ATR-related protein kinase upon DNA damage recognition.","volume":"66","author":"Ma","year":"2019","journal-title":"Curr. Genet."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.bbagen.2015.01.013","article-title":"Interaction of p53 with prolyl isomerases: healthy and unhealthy relationships.","volume":"1850","author":"Mantovani","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.1140321","article-title":"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.","volume":"316","author":"Matsuoka","year":"2007","journal-title":"Science"},{"key":"B58","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1016\/j.bmcl.2013.05.088","article-title":"Pin1 inhibitors: pitfalls, progress and cellular pharmacology.","volume":"23","author":"Moore","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.4161\/cc.7.18.6689","article-title":"Activation of ATR and related PIKKs.","volume":"7","author":"Mordes","year":"2008","journal-title":"Cell Cycle"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1101\/gad.1666208","article-title":"TopBP1 activates ATR through ATRIP and a PIKK regulatory domain.","volume":"22","author":"Mordes","year":"2008","journal-title":"Genes Dev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1182\/blood.v79.2.299.299","article-title":"Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid \u201cresistance\u201d in patients with acute promyelocytic leukemia.","volume":"79","author":"Muindi","year":"1992","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.cell.2012.02.016","article-title":"Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer\u2019s disease.","volume":"149","author":"Nakamura","year":"2012","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4161\/pri.22849","article-title":"Cis phosphorylated tau as the earliest detectable pathogenic conformation in Alzheimer disease, offering novel diagnostic and therapeutic strategies.","volume":"7","author":"Nakamura","year":"2013","journal-title":"Prion"},{"key":"B64","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.canlet.2019.10.043","article-title":"Prolyl isomerase Pin1 in metabolic reprogramming of cancer cells.","volume":"470","author":"Nakatsu","year":"2019","journal-title":"Cancer Lett."},{"key":"B65","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1042\/BJ20102162","article-title":"ATR signalling: more than meeting at the fork.","volume":"436","author":"Nam","year":"2011","journal-title":"Biochem. J."},{"key":"B66","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature04543","article-title":"The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.","volume":"440","author":"Pastorino","year":"2006","journal-title":"Nature"},{"key":"B67","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1126\/science.1135380","article-title":"Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc.","volume":"315","author":"Pinton","year":"2007","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.4161\/cbt.21093","article-title":"The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.","volume":"13","author":"Prevo","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"B69","first-page":"409","article-title":"Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis.","volume":"11","author":"Rippmann","year":"2000","journal-title":"Cell Growth Differ."},{"key":"B70","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/emmm.201302909","article-title":"Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast.","volume":"6","author":"Rustighi","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1242\/jcs.00276","article-title":"Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.","volume":"116","author":"Ryo","year":"2003","journal-title":"J. Cell. Sci."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.116","article-title":"Publisher correction: the essential kinase ATR: ensuring faithful duplication of a challenging genome.","volume":"18","author":"Saldivar","year":"2017","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev.biochem.73.011303.073723","article-title":"Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints.","volume":"73","author":"Sancar","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.molcel.2007.01.004","article-title":"Proline cis-trans isomerization controls autoinhibition of a signaling protein.","volume":"25","author":"Sarkar","year":"2007","journal-title":"Mol. Cell."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.jmb.2015.01.023","article-title":"Prolyl isomerization and its catalysis in protein folding and protein function.","volume":"427","author":"Schmidpeter","year":"2015","journal-title":"J. Mol. Biol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"5328","DOI":"10.1073\/pnas.0400053101","article-title":"All-trans retinoic acid\/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia.","volume":"101","author":"Shen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-124","article-title":"Prediction of cis\/trans isomerization in proteins using PSI-BLAST profiles and secondary structure information.","volume":"7","author":"Song","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"B78","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.mito.2014.08.003","article-title":"Regulation of mitochondrial apoptosis by Pin1 in cancer and neurodegeneration.","volume":"19","author":"Sorrentino","year":"2014","journal-title":"Mitochondrion"},{"key":"B79","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.molcel.2013.03.023","article-title":"Prolyl isomerase PIN1 regulates DNA double-strand break repair by counteracting DNA end resection.","volume":"50","author":"Steger","year":"2013","journal-title":"Mol. Cell."},{"key":"B80","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0022-2836(90)90159-j","article-title":"Occurrence and role of cis peptide bonds in protein structures.","volume":"214","author":"Stewart","year":"1990","journal-title":"J. Mol. Biol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4161\/cbt.9.2.10341","article-title":"Pin1 expression contributes to lung cancer: prognosis and carcinogenesis.","volume":"9","author":"Tan","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"B82","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0065-3233(08)60401-5","article-title":"Protein denaturation.","volume":"23","author":"Tanford","year":"1968","journal-title":"Adv. Protein Chem."},{"key":"B83","doi-asserted-by":"publisher","first-page":"5348","DOI":"10.1074\/jbc.M113.526442","article-title":"Differential regulation of cellular senescence and differentiation by prolyl isomerase Pin1 in cardiac progenitor cells.","volume":"289","author":"Toko","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1161\/CIRCRESAHA.113.301084","article-title":"Regulation of cardiac hypertrophic signaling by prolyl isomerase Pin1.","volume":"112","author":"Toko","year":"2013","journal-title":"Circ. Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.molonc.2011.07.002","article-title":"Targeting ATR and Chk1 kinases for cancer treatment: a new model for new (and old) drugs.","volume":"5","author":"Toledo","year":"2011","journal-title":"Mol. Oncol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"44289","DOI":"10.18632\/oncotarget.6247","article-title":"The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.","volume":"6","author":"Vendetti","year":"2015","journal-title":"Oncotarget"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3390\/ph3051311","article-title":"Prospects for the use of ATR inhibitors to treat cancer.","volume":"3","author":"Wagner","year":"2010","journal-title":"Pharmaceuticals"},{"key":"B88","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nm.3839","article-title":"Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer.","volume":"21","author":"Wei","year":"2015","journal-title":"Nat. Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1002\/art.39741","article-title":"Pin1-targeted therapy for systemic lupus erythematosus.","volume":"68","author":"Wei","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1126\/science.1073096","article-title":"Cancer. Addiction to oncogenes\u2013the Achilles heal of cancer.","volume":"297","author":"Weinstein","year":"2002","journal-title":"Science"},{"key":"B91","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-07-3293","article-title":"Oncogene addiction.","volume":"68","author":"Weinstein","year":"2008","journal-title":"Cancer Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ncponc0558","article-title":"Mechanisms of disease: oncogene addiction\u2013a rationale for molecular targeting in cancer therapy.","volume":"3","author":"Weinstein","year":"2006","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"47976","DOI":"10.1074\/jbc.c200538200","article-title":"Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage.","volume":"277","author":"Wulf","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156833","article-title":"Overexpression of PIN1 enhances cancer growth and aggressiveness with cyclin D1 induction in EBV-associated nasopharyngeal carcinoma.","volume":"11","author":"Xu","year":"2016","journal-title":"PLoS One"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1126\/science.278.5345.1957","article-title":"Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism.","volume":"278","author":"Yaffe","year":"1997","journal-title":"Science"},{"key":"B96","doi-asserted-by":"publisher","first-page":"13573","DOI":"10.1093\/nar\/gku1145","article-title":"Pin1-mediated Sp1 phosphorylation by CDK1 increases Sp1 stability and decreases its DNA-binding activity during mitosis.","volume":"42","author":"Yang","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nrc2107","article-title":"PIN1, the cell cycle and cancer.","volume":"7","author":"Yeh","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"B98","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nature01120","article-title":"The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults.","volume":"419","author":"Zacchi","year":"2002","journal-title":"Nature"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00094","article-title":"Oncogenic hijacking of the PIN1 signaling network.","volume":"9","author":"Zannini","year":"2019","journal-title":"Front. Oncol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nature01116","article-title":"The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response.","volume":"419","author":"Zheng","year":"2002","journal-title":"Nature"},{"key":"B101","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/s1097-2765(05)00083-3","article-title":"Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins.","volume":"6","author":"Zhou","year":"2000","journal-title":"Mol. Cell."},{"key":"B102","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrc.2016.49","article-title":"The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target.","volume":"16","author":"Zhou","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"B103","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s000180050026","article-title":"Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism.","volume":"56","author":"Zhou","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1126\/science.1083430","article-title":"Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes.","volume":"300","author":"Zou","year":"2003","journal-title":"Science"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00281\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T16:42:46Z","timestamp":1666456966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00281\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":104,"alternative-id":["10.3389\/fcell.2020.00281"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2020.00281","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"article-number":"281"}}